These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A post hoc analysis of transitioning to oral treatment with olanzapine or haloperidol after 24-hour intramuscular treatment in acutely agitated adult patients with schizophrenia. Battaglia J, Houston JP, Ahl J, Meyers AL, Kaiser CJ. Clin Ther; 2005 Oct; 27(10):1612-8. PubMed ID: 16330297 [Abstract] [Full Text] [Related]
10. Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatment. Wright P, Lindborg SR, Birkett M, Meehan K, Jones B, Alaka K, Ferchland-Howe I, Pickard A, Taylor CC, Roth J, Battaglia J, Bitter I, Chouinard G, Morris PL, Breier A. Can J Psychiatry; 2003 Dec; 48(11):716-21. PubMed ID: 14733451 [Abstract] [Full Text] [Related]
15. A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania. Meehan K, Zhang F, David S, Tohen M, Janicak P, Small J, Koch M, Rizk R, Walker D, Tran P, Breier A. J Clin Psychopharmacol; 2001 Aug; 21(4):389-97. PubMed ID: 11476123 [Abstract] [Full Text] [Related]
17. Effects of intramuscular olanzapine vs. haloperidol and placebo on QTc intervals in acutely agitated patients. Lindborg SR, Beasley CM, Alaka K, Taylor CC. Psychiatry Res; 2003 Jul 15; 119(1-2):113-23. PubMed ID: 12860365 [Abstract] [Full Text] [Related]
18. Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol. Andrezina R, Josiassen RC, Marcus RN, Oren DA, Manos G, Stock E, Carson WH, Iwamoto T. Psychopharmacology (Berl); 2006 Oct 15; 188(3):281-92. PubMed ID: 16953381 [Abstract] [Full Text] [Related]
19. Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study. Andrezina R, Marcus RN, Oren DA, Manos G, Stock E, Carson WH, McQuade RD. Curr Med Res Opin; 2006 Nov 15; 22(11):2209-19. PubMed ID: 17076982 [Abstract] [Full Text] [Related]